Neuropathic Pain Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Chronic Neuropathic Pain
Sangamo Therapeutics27 enrolled11 locationsNCT06980948
Recruiting
Phase 2
Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap
Neuropathic PainNeuroma
Massachusetts General Hospital20 enrolled1 locationNCT06915662